Not every health threat is easy to spot. Screening tests can prevent some cancers or catch them early, often before symptoms appear and when treatment is more likely to work best. Talk with your doctor about which screenings are right for you and when to get them. Another threat that's easy to miss: too much UV exposure from the sun, which can lead to skin cancer. Simple options like shade, a wide-brimmed hat, sunglasses, protective clothing, and broad-spectrum sunscreen with an SPF 15 or higher can help lower your risk. #SharkWeek# #ChronicDisease# #CatchCancerEarly# #CancerScreening# #CancerPrevention#

We recently received authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for our Phase 1/2 clinical study evaluating mRNA-4194, an investigational mRNA-based vaccine for people with Lynch syndrome, an inherited condition that increases the risk of cancer. David Berman, our Chief Development Officer, sat down for an episode of IR Insights to provide an overview of this innovative program and Moderna’s research in the cancer prevention vaccine space:

Today, along with the University of Oxford, we announced that a Phase 1/2 study of mRNA-4194, our investigational cancer vaccine for Lynch syndrome, has received Medicines and Healthcare products Regulatory Agency (MHRA) authorization in the UK. The trial is part of a scientific collaboration between Moderna and the University of Oxford to advance a novel mRNA approach to cancer prevention. Read more: